The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env.
Human immunodeficiency virus type 1 (HIV-1)-mediated depletion of CD4+ lymphocytes in an infected individual is the hallmark of progression to AIDS. However, the mechanism for this depletion remains unclear. To identify mechanisms of HIV-1-mediated CD4 T-cell death, two similar viral isolates obtained from a rapid progressor patient with significantly different pathogenic phenotypes were studied. One isolate (R3A) demonstrates enhanced pathogenesis in both in vivo models and relevant ex vivo lymphoid organ model systems compared to another isolate, R3B. The pathogenic determinants were previously mapped to the V5-gp41 envelope region, correlating functionally with enhanced fusion activity and elevated CXCR4 binding affinity. To further elucidate specific differences between R3A and R3B within the V5-gp41 domains that enhance CD4 depletion, R3A-R3B chimeras to study the V5-gp41 region were developed. Our data demonstrate that six residues in the ectodomain of R3A provide the major determinant for both enhanced Env-cell fusion and pathogenicity. Furthermore, three amino acid differences in the heptad repeat 2 (HR-2) domain of R3A determined its fusion activity and significantly elevated its pathogenic activity. The chimeric viruses with enhanced fusion activity, but not elevated CXCR4 affinity, correlated with high pathogenicity in the thymus organ. We conclude that the functional domain of a highly pathogenic HIV-1 Env is determined by mutations in the HR-2 region that contribute to enhanced fusion and CD4 T-cell depletion.
Sivaraman
Vijay
V
Department of Microbiology and Immunology, School of Medicine, The University of North Carolina, Chapel Hill, North Carolina 27599-7295, USA.
Zhang
Liguo
L
Meissner
Eric G
EG
Jeffrey
Jerry L
JL
Su
Lishan
L
D015496:CD4-Positive T-Lymphocytes / Q000821:virology; D002460:Cell Line; D015700:HIV Envelope Protein gp41 / Q000502:physiology; D015658:HIV Infections / Q000821:virology; D015497:HIV-1 / Q000472:pathogenicity*; D016297:Mutagenesis, Site-Directed; D019718:Receptors, CXCR4 / Q000502:physiology; D053585:Virus Attachment; D053586:Virus Internalization; D054299:env Gene Products, Human Immunodeficiency Virus / Q000502:physiology*
D015700:HIV Envelope Protein gp41; D019718:Receptors, CXCR4; D054299:env Gene Products, Human Immunodeficiency Virus